CEBPA and acute myeloid leukemia: In one CEBPA (08H082) and one NUP98-NSD1 (11H027) samples, TAP was also able to detect a 4 bp NPM1 insertion, an important AML biomarker, in exon 12 where most reported mutations reside [55].